These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Viral Noncoding RNAs in Cancer Biology. Li Z; Fu S; Sun LQ Adv Exp Med Biol; 2016; 927():367-89. PubMed ID: 27376743 [TBL] [Abstract][Full Text] [Related]
6. The Role of SUMO E3 Ligases in Signaling Pathway of Cancer Cells. Shi X; Du Y; Li S; Wu H Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408996 [TBL] [Abstract][Full Text] [Related]
7. Manipulation of ubiquitin/SUMO pathways in human herpesviruses infection. Gan J; Qiao N; Strahan R; Zhu C; Liu L; Verma SC; Wei F; Cai Q Rev Med Virol; 2016 Nov; 26(6):435-445. PubMed ID: 27550835 [TBL] [Abstract][Full Text] [Related]
8. Kaposi's sarcoma-associated herpesvirus K-Rta exhibits SUMO-targeting ubiquitin ligase (STUbL) like activity and is essential for viral reactivation. Izumiya Y; Kobayashi K; Kim KY; Pochampalli M; Izumiya C; Shevchenko B; Wang DH; Huerta SB; Martinez A; Campbell M; Kung HJ PLoS Pathog; 2013; 9(8):e1003506. PubMed ID: 23990779 [TBL] [Abstract][Full Text] [Related]
9. Viral Mimicry to Usurp Ubiquitin and SUMO Host Pathways. Wimmer P; Schreiner S Viruses; 2015 Aug; 7(9):4854-72. PubMed ID: 26343706 [TBL] [Abstract][Full Text] [Related]
10. Molecular mechanisms in SUMO conjugation. Varejão N; Lascorz J; Li Y; Reverter D Biochem Soc Trans; 2020 Feb; 48(1):123-135. PubMed ID: 31872228 [TBL] [Abstract][Full Text] [Related]
11. Viruses and human cancer: from detection to causality. Sarid R; Gao SJ Cancer Lett; 2011 Jun; 305(2):218-27. PubMed ID: 20971551 [TBL] [Abstract][Full Text] [Related]
12. The Epstein-Barr virus miR-BHRF1-1 targets RNF4 during productive infection to promote the accumulation of SUMO conjugates and the release of infectious virus. Li J; Callegari S; Masucci MG PLoS Pathog; 2017 Apr; 13(4):e1006338. PubMed ID: 28414785 [TBL] [Abstract][Full Text] [Related]
13. Sumoylation and Its Contribution to Cancer. Lee JS; Choi HJ; Baek SH Adv Exp Med Biol; 2017; 963():283-298. PubMed ID: 28197919 [TBL] [Abstract][Full Text] [Related]
14. Viral Interplay with the Host Sumoylation System. Wilson VG Adv Exp Med Biol; 2017; 963():359-388. PubMed ID: 28197923 [TBL] [Abstract][Full Text] [Related]
15. Mechanism of Adenovirus E4-ORF3-Mediated SUMO Modifications. Sohn SY; Hearing P mBio; 2019 Feb; 10(1):. PubMed ID: 30808699 [TBL] [Abstract][Full Text] [Related]
16. Multifaceted roles of SUMO in DNA metabolism. Thu YM Nucleus; 2024 Dec; 15(1):2398450. PubMed ID: 39287196 [TBL] [Abstract][Full Text] [Related]
17. SUMO and Cytoplasmic RNA Viruses: From Enemies to Best Friends. El Motiam A; Vidal S; Seoane R; Bouzaher YH; González-Santamaría J; Rivas C Adv Exp Med Biol; 2020; 1233():263-277. PubMed ID: 32274761 [TBL] [Abstract][Full Text] [Related]
18. SUMOylation of nonstructural 5A protein regulates hepatitis C virus replication. Lee HS; Lim YS; Park EM; Baek SH; Hwang SB J Viral Hepat; 2014 Oct; 21(10):e108-17. PubMed ID: 24602294 [TBL] [Abstract][Full Text] [Related]
19. E2-mediated small ubiquitin-like modifier (SUMO) modification of thymine DNA glycosylase is efficient but not selective for the enzyme-product complex. Coey CT; Fitzgerald ME; Maiti A; Reiter KH; Guzzo CM; Matunis MJ; Drohat AC J Biol Chem; 2014 May; 289(22):15810-9. PubMed ID: 24753249 [TBL] [Abstract][Full Text] [Related]
20. SUMO pathway components as possible cancer biomarkers. Mattoscio D; Chiocca S Future Oncol; 2015; 11(11):1599-610. PubMed ID: 26043214 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]